Dec 11 (Reuters) - Bristol Myers Squibb said on Monday it will make an upfront payment of $800 million to SystImmune to co-develop and co-commercialize a type of antibody-drug conjugates (ADC) treatment that precisely targets cancer cells. (Reporting by Christy Santhosh; Editing by Shinjini Ganguli)
Walmart's CEO went from earning $6.50 an hour to $25 million a year—here are his three tips for climbing the corporate ladder like him
Donald Trump’s aides have drawn up secret plans to oust the chairman of the Federal Reserve and allow the president to set interest rates, according to reports.
These proven wealth builders could be exactly what you're searching for right now.
Here's what could happen next to Microsoft shares.
The property report includes 85 major metropolitan areas in the U.S. with populations of at least 750,000.
It's been an "everything buy bonds" bull rally in markets for months, but BofA is cautiously watching a couple of indicators.
Jamie Dimon and Jerome Powell are taking the European viewpoint on soaring debt levels in the U.S.
"We are not very ambitious. I should be careful about talking about work-life balance, but the Americans just work harder.”
Baron, whose largest position is in Tesla, is betting the new shift in strategy for Tesla’s low-cost car will fill its increasingly empty factories.
Given the better-than-expected macroeconomic conditions to start 2024, SoFi could revise forecasts higher.